Literature DB >> 16583091

[HIV-1 diversity: a tool for studying the pandemic].

Mônica Edelenyi Pinto1, Claudio José Struchiner.   

Abstract

HIV-1 is remarkable for the diversity of strains comprising the HIV/AIDS pandemic. In the last decade, classification of viral variants as groups, subtypes, and circulating recombinant forms (CRF) and the observation of specific mutational patterns have become powerful tools for studying viral molecular dynamics. Monitoring the worldwide distribution of HIV-1 diversity has been used in both epidemiological surveillance programs and in reconstructing the history of regional epidemics. Specific patterns of virus spatial distribution also suggest differences in pathogenicity and transmissibility among the various subtypes. Molecular analyses of viral sequences allow estimating the rate of divergence among variants and the dynamic forces shaping the phylogenetic trees.

Entities:  

Mesh:

Year:  2006        PMID: 16583091     DOI: 10.1590/s0102-311x2006000300002

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  3 in total

1.  Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of São Paulo, Brazil.

Authors:  Rosana Alcalde; Monick L Guimarães; Alberto J S Duarte; Jorge Casseb
Journal:  Virol J       Date:  2012-08-09       Impact factor: 4.099

2.  Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil.

Authors:  Kledoaldo Lima; Élcio de Souza Leal; Ana Maria Salustiano Cavalcanti; Daniela Medeiros Salustiano; Luzidalva Barbosa de Medeiros; Sirleide Pereira da Silva; Heloísa Ramos Lacerda
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

3.  Geolocalization of HIV-1 subtypes and resistance mutations of patients failing antiretroviral therapy in Salvador - Brazil.

Authors:  Antonio Walter de Oliveira Filho; Carlos Brites
Journal:  Braz J Infect Dis       Date:  2017-04-05       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.